CardioKG provides a detailed view of the heart’s structure and function which dramatically improves the accuracy of predicting which genes are linked to disease and whether existing drugs could treat them.
A research team at Oregon Health & Science University has discovered a promising new drug combination that may help people with acute myeloid leukemia overcome resistance to one of the most common frontline therapies.
Researchers at Lund University in Sweden have identified a combination of statins and phenothiazines that is particularly promising in the treatment of the aggressive form of neuroblastoma.
Texas A&M University researchers have found that a brief virtual reality (VR) simulation of a near-death experience can sharply reduce people’s anxiety about death. In a small pilot study of about 60 young adults, participants reported a 75% decrease in their fear of death after a single 12-minute session.
A new international study led by Prof. Carmit Levy of the Department of Human Genetics and Biochemistry at the Gray Faculty of Medical & Health Sciences at Tel Aviv University finds that melanoma cancer cells paralyze immune cells by secreting extracellular vesicles (EVs).
A research team from the Department of Medicine, School of Clinical Medicine, LKS Faculty of Medicine at the University of Hong Kong (HKUMed) has uncovered a key biological mechanism that explains how exercise maintains strong bones.
The research team led by Professor Sang Wan Lee from the Department of Brain and Cognitive Sciences, in collaboration with IBM AI Research, has deciphered how the human brain manages goal changes in uncertain situations.
Harvard Medical School researchers have uncovered crucial insights into how an emerging class of antiviral drugs works.
Cclcium alpha-ketoglutarate (CaAKG), a safe, naturally occurring metabolite commonly studied for healthy aging, can restore key memory-related brain functions that have been disrupted in Alzheimer’s disease.
A joint research team led by Professor Steve Park from the Department of Materials Science and Engineering and Professor Sangyong Jon from the Department of Biological Sciences has developed a powder-type hemostatic agent that forms a powerful hydrogel barrier.